N‐terminal mutations activate the leukemogenic potential of the myristoylated form of c‐abl.

[57] Sequencing end-labeled DNA with base-specific chemical cleavages

Allan M. Maxam, Walter Gilbert · Methods in enzymology on CD-ROM/Methods in enzymology · 1980 · 14.7K citations

Pharmacy, Biotechnology, Molecular Biology +13

Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes

Marilyn Kozak · Cell · 1986 · 4.9K citations

Life Sciences, Genetics, Molecular Biology +14

Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter.

Peter J. Southern, Paul Berg · PubMed · 1982 · 2.8K citations

Life Sciences, Genetics, Molecular Biology +17

Transforming gene product of Rous sarcoma virus phosphorylates tyrosine

Tony Hunter, Bartholomew M. Sefton · Proceedings of the National Academy of Sciences · 1980 · 2.4K citations · Full text

Life Sciences, Cell Biology, Molecular Biology +11

The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF 1

Charles J. Sherr, Carl W. Rettenmier, Rosalba Sacca et al. · Cell · 1985 · 1.6K citations

Life Sciences, Immunology, Molecular Biology +11